Braf mutated CRC:
Array BioPharma has a phase iii trial-BEACON- using three drug combo of Encorafenib.Binimetinib and Cetuximab,to be soon presented at an ASCO GI conference,as per markets.business insider.com
Comments
-
Is this for V600E or BRAF in
Is this for V600E or BRAF in general? I think that most people don't know what their gene mutations are so maybe a bit more description so that people could see whether or not this would be useful. Also, location of the trial might be useful as something across the country may not be helpful.
0 -
Trial is in Europe;V600E is Braf mutation involved
For those who have this mutation,you might want to research whats being done with other cancers,like melanoma,which can also be applied in CRC> If successful,more will be heard in US about it...
The site onclive.com might alsoprovide ideas....
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.9K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 398 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 794 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 63 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 540 Sarcoma
- 734 Skin Cancer
- 654 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards